Browsing: Health policy

Many of us may be familiar with the endless Commission on Cancer (CoC) accreditation standards, and this editorial asks: why…

In a move that yesterday left many a solo-practitioner in the rad onc world stunned, ASTRO released a letter to…

A Medicare claims analysis identified four no- or low-value oncology interventions: (1) denosumab for castration sensitive prostate cancer, (2) a…

This comprehensive review of the impact of Medicaid expansions ushered in by the Affordable Care Act indicates an associated increase…